345 related articles for article (PubMed ID: 11517051)
1. Stenting as first option for endovascular treatment of malignant superior vena cava syndrome.
Lanciego C; Chacón JL; Julián A; Andrade J; López L; Martinez B; Cruz M; García-García L
AJR Am J Roentgenol; 2001 Sep; 177(3):585-93. PubMed ID: 11517051
[TBL] [Abstract][Full Text] [Related]
2. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome.
Lanciego C; Pangua C; Chacón JI; Velasco J; Boy RC; Viana A; Cerezo S; García LG
AJR Am J Roentgenol; 2009 Aug; 193(2):549-58. PubMed ID: 19620456
[TBL] [Abstract][Full Text] [Related]
3. Endovascular treatment of superior vena cava syndrome.
Duvnjak S; Andersen P
Int Angiol; 2011 Oct; 30(5):458-61. PubMed ID: 21804485
[TBL] [Abstract][Full Text] [Related]
4. Endovascular stenting as a first choice for the palliation of superior vena cava syndrome.
Kim YI; Kim KS; Ko YC; Park CM; Lim SC; Kim YC; Park KO; Yoon W; Kim YH; Kim JK; Ahn SJ
J Korean Med Sci; 2004 Aug; 19(4):519-22. PubMed ID: 15308841
[TBL] [Abstract][Full Text] [Related]
5. Sequential treatment of superior vena cava syndrome caused by of non-small cell carcinoma lung cancer (NSCLC) with vascular stenting and iodine-125 implantation.
Xiao L; Li Z; Wu L; Sun Z; Yu X
Technol Cancer Res Treat; 2009 Aug; 8(4):281-7. PubMed ID: 19645521
[TBL] [Abstract][Full Text] [Related]
6. [Observation of endovascular stent insertion for non-small cell lung cancer patients with superior vena cava syndrome].
Li F; Sun X; Liang S; Jiang S; Mao L
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):47-51. PubMed ID: 25877319
[TBL] [Abstract][Full Text] [Related]
7. Stenting in malignant obstruction of superior vena cava.
Shah R; Sabanathan S; Lowe RA; Mearns AJ
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):335-40. PubMed ID: 8751500
[TBL] [Abstract][Full Text] [Related]
8. Stent implantation in patients with superior vena cava syndrome.
Gross CM; Krämer J; Waigand J; Uhlich F; Schröder G; Thalhammer C; Dechend R; Gulba DC; Dietz R
AJR Am J Roentgenol; 1997 Aug; 169(2):429-32. PubMed ID: 9242747
[TBL] [Abstract][Full Text] [Related]
9. Superior vena cava stent placement: results with the Wallstent endoprosthesis.
Hennequin LM; Fade O; Fays JG; Bic JF; Jaafar S; Bertal A; Anthoine D; Bernadac PA
Radiology; 1995 Aug; 196(2):353-61. PubMed ID: 7617844
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of endovascular prostheses as initial treatment for superior vena cava syndrome of malignant cause].
Talens A; Ferrer S; González-Cruz A; Blanco E; García-Ferrer L; Iranzo V; Camps C
Med Clin (Barc); 2013 Jan; 140(2):59-65. PubMed ID: 22237043
[TBL] [Abstract][Full Text] [Related]
11. A new nitinol stent for use in superior vena cava syndrome. Initial clinical experience.
Andersen PE; Midtgaard A; Brenøe AS; Elle B; Duvnjak S
J Cardiovasc Surg (Torino); 2015 Dec; 56(6):877-81. PubMed ID: 26212865
[TBL] [Abstract][Full Text] [Related]
12. [Interventional therapy for lung cancer patients with superior vena cava syndrome].
Luo J; Chen B; Jiang S; Zhou SW
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):627-31. PubMed ID: 24314224
[TBL] [Abstract][Full Text] [Related]
13. Vascular stenting for palliation of superior vena cava obstruction in non-small-cell lung cancer patients: a future 'standard' procedure?
Greillier L; Barlési F; Doddoli C; Durieux O; Torre JP; Gimenez C; Kleisbauer JP
Respiration; 2004; 71(2):178-83. PubMed ID: 15031575
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of superior vena cava syndrome in cancer patients with intravascular stent and local thrombolysis].
Zhang F; Wu P; Huang J
Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):507-9. PubMed ID: 11235576
[TBL] [Abstract][Full Text] [Related]
15. [Stenting for superior vena cava obstruction associated with lung cancer: monocentric study].
Pierre MC; Chabbert V; Lozano S; Bigay-Game L; Lévêque N; Desloques L; Otal P; Rousseau H; Didier A; Mazières J
Rev Mal Respir; 2009 Sep; 26(7):744-50. PubMed ID: 19953016
[TBL] [Abstract][Full Text] [Related]
16. Retrospective study in 23 patients of the self-expanding sinus-XL stent for treatment of malignant superior vena cava obstruction caused by non-small cell lung cancer.
Mokry T; Bellemann N; Sommer CM; Heussel CP; Bozorgmehr F; Gnutzmann D; Kortes NA; Kauczor HU; Radeleff B; Stampfl U
J Vasc Interv Radiol; 2015 Mar; 26(3):357-65. PubMed ID: 25638748
[TBL] [Abstract][Full Text] [Related]
17. Endovascular stenting in neoplastic superior vena cava syndrome prior to chemotherapy or radiotherapy.
Bierdrager E; Lampmann LE; Lohle PN; Schoemaker CM; Schijen JH; Palmen FM; van der Heul C
Neth J Med; 2005 Jan; 63(1):20-3. PubMed ID: 15719848
[TBL] [Abstract][Full Text] [Related]
18. Endovascular stenting in the management of malignant superior vena cava obstruction: comparing safety, effectiveness, and outcomes between primary stenting and salvage stenting.
Leung ST; Sung TH; Wan AY; Leung KW; Kan WK
Hong Kong Med J; 2015 Oct; 21(5):426-34. PubMed ID: 26139689
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous stenting of superior vena cava syndrome: treatment outcome in patients with benign and malignant etiology.
Barshes NR; Annambhotla S; El Sayed HF; Huynh TT; Kougias P; Dardik A; Lin PH
Vascular; 2007; 15(5):314-21. PubMed ID: 17976332
[TBL] [Abstract][Full Text] [Related]
20. Brachiocephalic-superior vena cava metallic stenting in malignant superior vena cava obstruction.
Lau KY; Tan LT; Wong WW; Lee AS
Ann Acad Med Singap; 2003 Jul; 32(4):461-5. PubMed ID: 12968550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
